The Latest Cardiac and Vascular News
Non-invasive, AI-enabled product helps CT readers to accurately*, efficiently, and consistently identify narrowings in the coronary arteries, advancing the HeartFlow portfolio MOUNTAIN VIEW, Calif., April 17, 2023 (GLOBE NEWSWIRE) — HeartFlow, Inc. today announced the launch of the RoadMap analysis, a new AI-enabled product that assists CT readers to accurately*, […]
Hoag is one of the first three sites in the nation enrolling patients in a post-market study Hoag cardiac surgeons are among an elite class of specialists experienced with this latest generation valve option Study expected to grow to include centers around the world NEWPORT BEACH, Calif., April 17, 2023 /PRNewswire/ — […]
BERKELEY HEIGHTS, N.J., April 17, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced the appointment of Robert A. Stewart to the CorMedix Board of Directors. Following the appointment […]
Compounds that activate SERCA2a may lead to novel therapies for heart failure WARRINGTON, Pa., April 17, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced that the European Patent Office has granted Patent […]
Hutrukin, A Therapy Discovered and Manufactured at XBiotech, Is Aimed to Reduce Brain Injury after Stroke AUSTIN, Texas, April 17, 2023 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) has enrolled the first subject in a randomized, open-label, placebo-controlled dose escalation clinical study to evaluate safety and pharmacokinetics of Hutrukin. Hutrukin […]
DUBLIN, Ireland and BRIDGEWATER, N.J., April 17, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company’s Board of Directors has appointed Aaron Berg, currently Amarin’s Executive Vice President and President of the U.S. Business, as Interim President and Chief Executive Officer (CEO). In addition, the board […]
12-month results reinforce versatility and durability for the treatment of paroxysmal and persistent AFib with the first-of-its-kind pulsed field ablation, radiofrequency, and high density mapping Sphere-9™ Catheter Medtronic today announced the 12-month findings that supported the Affera™ Mapping and Ablation System CE Mark, demonstrating that the Sphere-9™ Catheter can successfully […]
Market-leading Philips PACS is now available on AWS for industry-leading availability, reliability, security, and AI-supported workflow enhancements Expansion of the collaboration with AWS will support the development and deployment of generative AI applications that further support efficient clinical workflows and enhance diagnostic capabilities Amsterdam, the Netherlands and Chicago, USA – Royal […]
Financing led by Andera Partners including Cormorant Asset Management, Taglich Brothers Inc., Squarepoint Capital, and Richmond Brothers to Support Premarket Approval of Revivent TC® System for Patients with Ischemic Heart Failure MANSFIELD, Mass., April 13, 2023 /PRNewswire/ — BioVentrix, Inc., a privately held medical device company developing minimally invasive therapies to directly treat the dilated left […]
DENVER, April 13, 2023 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) (the “Company”) today provided a business update and announced preliminary financial results for the quarter ended March 31, 2023. The preliminary results have not been audited and are subject to change. First Quarter 2023 Preliminary Results and Key Points (Unaudited) Received 13 new orders […]
